State Street Corp Imara Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.0 - $21.0 $0 - $791,658	-37,698 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$3.73 - $5.2 $61,545 - $85,800	16,500 Added 77.84%	37,698 $154,000
Q2 2021 Aug 16, 2021	SELL	$6.78 - $9.04 $606,043 - $808,058	-89,387 Reduced 80.83%	21,198 $167,000
Q1 2021 May 17, 2021	BUY	$8.18 - $23.98 $43,190 - $126,614	5,280 Added 5.01%	110,585 $933,000
Q4 2020 Feb 16, 2021	BUY	$15.81 - $29.0 $652,826 - $1.2 Million	41,292 Added 64.51%	105,305 $2.32 Million

Q3 2020 Nov 10, 2020	BUY	$18.75 - $28.58 $144,581 - $220,380	7,711 Added 13.7%	64,013 $1.3 Million
Q2 2020 Aug 14, 2020	BUY	$15.6 - $54.87 $878,311 - $3.09 Million	56,302 New	56,302 $1.56 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.